Search Within

David R Spriggs

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (8)
Groups
  1. Sloan Kettering Institute Postdocs (8)
  2. Gynecology Disease Management Team (6)
  3. Department of Medicine (5)
  4. Department of Pathology and Laboratory Medicine (5)
  5. GDMT, Medicine (5)
  6. GSK Faculty (5)

More Groups

People
  1. Carol Aghajanian (4)
  2. David Solit (3)
  3. Dharmarao Thapi (3)
  4. Paul Sabbatini (3)
  5. Alexia Iasonos (2)
  6. Barry Taylor (2)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2018 (1)
  4. 2017 (1)
  5. 2016 (1)
  6. 2015 (1)

More Years

Publications
  1. Clinical Cancer Research (2)
  2. ACS Chemical Biology (1)
  3. Cancer Discovery (1)
  4. Cancers (1)
  5. Journal of Clinical Oncology (1)
  6. Molecular Cancer Therapeutics (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. American Chemical Society (1)
  3. American Society of Clinical Oncology (1)
  4. Elsevier Science Inc. (1)
  5. MDPI (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dual fluorescence isogenic synthetic lethal kinase screen and high-content secondary screening for MUC16/CA125-selective agents
    Journal Article

    Rao, T. D.; Xu, M.; Eng, S.; Yang, G.; Manson, R.; Rosales, N.; Kumar, R.; Veillard, I. E.; Zhou, Q.; Iasonos, A.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation
    Journal Article

    Nemieboka, B.; Sharma, S. K.; Rao, T. D.; Edwards, K. J.; Yan, S.; Wang, P.; Ragupathi, A.; Piersigilli, A.; Spriggs, D. R.; Lewis, J. S.
    Nuclear Medicine and Biology (2020)

    Fulltext@MSK | Save
  • Clinical utility of prospective molecular characterization in advanced endometrial cancer
    Journal Article

    Soumerai, T. E.; Donoghue, M. T. A.; Bandlamudi, C.; Srinivasan, P.; Chang, M. T.; Zamarin, D.; Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Tew, W. P.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Antibodies against specific MUC16 glycosylation sites inhibit ovarian cancer growth
    Journal Article

    Rao, T. D.; Fernández-Tejada, A.; Axelrod, A.; Rosales, N.; Yan, X.; Thapi, S.; Wang, A.; Park, K. J.; Nemieboka, B.; Xiang, J.; more...
    ACS Chemical Biology (2017)

    Fulltext@MSK | Save
  • A phase I study of unimolecular pentavalent (Globo-H-GM2-sTn-TF-Tn) immunization of patients with epithelial ovarian, fallopian tube, or peritoneal cancer in first remission
    Journal Article

    O’Cearbhaill, R. E.; Ragupathi, G.; Zhu, J.; Wan, Q.; Mironov, S.; Yang, G.; Spassova, M. K.; Iasonos, A.; Kravetz, S.; Ouerfelli, O.; more...
    Cancers (2016)

    Fulltext@MSK | Save
  • Extreme outlier analysis identifies occult mitogen-activated protein kinase pathway mutations in patients with low-grade serous ovarian cancer
    Journal Article

    Grisham, R. N.; Sylvester, B. E.; Won, H.; McDermott, G.; DeLair, D.; Ramirez, R.; Yao, Z.; Shen, R. L.; Dao, F.; Bogomolniy, F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients
    Journal Article

    Sabbatini, P.; Tsuji, T.; Ferran, L.; Ritter, E.; Sedrak, C.; Tuballes, K.; Jungbluth, A. A.; Ritter, G.; Aghajanian, C.; Bell-Mcguinn, K.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Genomic complexity and AKT dependence in serous ovarian cancer
    Journal Article

    Hanrahan, A. J.; Schultz, N.; Westfal, M. L.; Sakr, R. A.; Giri, D. D.; Scarperi, S.; Janakiraman, M.; Olvera, N.; Stevens, E. V.; She, Q. B.; more...
    Cancer Discovery (2012)

    Fulltext@MSK | Save